Pharmaceutical News

RSS

4 out of 5 people on antidepressant drugs are unaware of the side effects

New research has found that less than half of practitioners have mental health training and thousands of patients are left in the dark about their medications.

3 Oct 2019

Fewer than half of U.S. adults get annual flu shot, shows study

So far this calendar year, 1,243 people scattered around 31 states had confirmed measles, the highest number of measles cases reported in the U.S.

3 Oct 2019

Aspirin may reduce adverse effects of air pollution exposure on lung function

A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs like aspirin may lessen the adverse effects of air pollution exposure on lung function.

3 Oct 2019

Study: Aspirin is not recommended for people who never had a heart attack or stroke

If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research.

3 Oct 2019

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

3 Oct 2019

First-of-its-kind study shows antidepressants are safe

Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.

2 Oct 2019

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Antidepressants are generally safe, according to a new study by an international team of researchers. By assessing evidence from 45 meta-analyses, which combined the results from many studies, the researchers did not find strong evidence of adverse health outcomes associated with antidepressant use.

2 Oct 2019

Heart failure medication often prescribed in lower dosages than recommended

Important medication for the treatment of heart failure are often prescribed in lower dosages than recommended by international guidelines.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

Analyses of two clinical trials predict response to asthma drug by COPD patients

Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association.

30 Sep 2019

People with severe insomnia may benefit from sedatives, shows study

Insomnia is a driver of suicide, and particularly people with severe insomnia may safely benefit from taking a sedative to help address their sleep problems as it reduces their suicidal thoughts, investigators report.

30 Sep 2019

Study: Heart disease is associated with allopurinol-related severe skin reactions

Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).

30 Sep 2019

Higher dosage of statins can increase risk of osteoporosis, shows study

At low doses, statins could protect against bone resorption. But the higher the dosage of cholesterol-lowering drugs, the greater the probability of osteoporosis, an analysis of millions of patient data by the Complexity Science Hub Vienna shows.

30 Sep 2019

US Government supports Kinoxis Therapeutics to end opioid addiction

Kinoxis Therapeutics has been awarded a grant for a potential of up to $US4.6 million ($6.8 million) under the USA National Institutes of Health Helping to End Addiction Long-Term, or the NIH HEAL Initiative.

30 Sep 2019

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.

30 Sep 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

Pharmaceutical News

4 out of 5 people on antidepressant drugs are unaware of the side effects

Fewer than half of U.S. adults get annual flu shot, shows study

Aspirin may reduce adverse effects of air pollution exposure on lung function

Study: Aspirin is not recommended for people who never had a heart attack or stroke

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

First-of-its-kind study shows antidepressants are safe

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Heart failure medication often prescribed in lower dosages than recommended

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Analyses of two clinical trials predict response to asthma drug by COPD patients

People with severe insomnia may benefit from sedatives, shows study

Study: Heart disease is associated with allopurinol-related severe skin reactions

Higher dosage of statins can increase risk of osteoporosis, shows study

US Government supports Kinoxis Therapeutics to end opioid addiction

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

FDA warns about Ranitidine containing known carcinogen NDMA

High-risk heart patients may not require long-term aspirin use after stent placement

Arthritis drug could be used to treat lichen planus skin rash

Study finds nearly one in three patients with lupus uses prescription opioids for pain

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News